Chipmos Technologies IMOS
71.78
2.06
2.95%
as of 25 Sep
- Market cap
- $2.4B
- P/E
- 34.9×
Follow IMOS
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
31.23 | 48.35 | 68.91 | 119.44 |
+8 more quarters Free account |
P/S ratio |
2.61 | 1.54 | 1.38 | 0.95 | |
P/FCF ratio |
0.00 | 0.00 | 83.57 | 0.00 | |
P/Operating CF |
58.87 | 120.93 | 18.44 | 16.92 | |
P/B ratio |
2.85 | 1.61 | 1.38 | 0.87 | |
Price to Tangible BV |
2.85 | 1.61 | 1.38 | 0.87 | |
EV/Sales |
2.73 | 1.63 | 1.43 | 1.06 | |
EV/EBITDA |
10.01 | 6.29 | 5.49 | 4.06 | |
EV/Operating CF |
16.18 | 12.57 | 8.57 | 5.69 | |
EV/FCF |
(885.90) | (1,610.23) | 86.69 | (323.94) | |
Quick Ratio |
1.85 | 1.92 | 2.01 | 2.07 | |
Current Ratio |
2.39 | 2.44 | 2.40 | 2.47 | |
Net Debt/EBITDA |
1.54 | 1.40 | 0.73 | 1.35 | |
Debt/Assets |
33.94% | 33.36% | 35.74% | 35.84% | |
Debt/Equity |
0.64 | 0.61 | 0.68 | 0.66 | |
Asset Turnover |
0.59 | 0.60 | 0.54 | 0.50 | |
Operating CF/Net income |
1.35 | 0.65 | 3.21 | 3.39 | |
Capex/Depreciation |
(1.52) | (1.10) | (0.57) | (0.60) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
4.21% | 4.20% | 4.38% | 4.27% | |
Selling, General and Administrative Expense of Revenue |
2.38% | 2.31% | 2.43% | 2.41% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.59% | 0.00% | |
Graham Net Nets |
0.05 | 0.10 | 0.11 | 0.17 | |
Graham Number |
32.28 | 19.23 | 14.43 | 8.92 | |
Earnings Yield |
3.20% | 2.07% | 1.45% | 0.84% | |
Free Cash Flow Yield |
(0.12%) | (0.07%) | 1.20% | (0.34%) | |
Revenue per Share |
6.69 | 6.26 | 5.72 | 5.81 | |
Operating CF per Share |
1.09 | 0.30 | 1.61 | 1.13 | |
Capex per Share |
(1.68) | (1.24) | (0.55) | (0.75) | |
Free Cash Flow per Share |
(0.59) | (0.94) | 1.06 | 0.37 | |
Cash per Share |
11.41 | 11.27 | 13.44 | 12.37 | |
Shareholders Equity per Share |
22.51 | 22.22 | 21.53 | 22.09 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
22.51 | 22.22 | 21.53 | 22.09 | |
Free Cash Flow |
(20.53) | (33.05) | 37.69 | 13.24 | |
Working Capital |
470.95 | 453.55 | 467.52 | 459.02 | |
Capital Expenditures |
(58.73) | (43.41) | (19.38) | (26.67) | |
Net Current Asset Value |
109.65 | 130.03 | 120.56 | 116.66 | |
EV/EBIT |
29.93 | 26.97 | 29.97 | 38.99 | |
Capex to Sales |
0.25 | 0.20 | 0.10 | 0.13 | |
Net Profit Margin |
12.08% | 7.28% | 8.74% | 5.73% | |
Price to Operating Income |
28.58 | 25.39 | 28.89 | 35.00 | |
| Other line items | |||||
Average Receivables |
208.52 | 187.41 | 175.07 | 208.60 | |
Average Payables |
39.40 | 34.18 | 29.25 | 31.56 | |
Average Inventory |
126.88 | 112.71 | 94.59 | 97.89 | |
Average Assets |
1,451.60 | 1,365.18 | 1,414.84 | 1,419.19 | |
Average Common Equity |
771.78 | 767.94 | 763.59 | 775.35 |
Columns are period end dates · fundamentals updated 23 Sep 2026